Sign in →

Test Code FBLAS MVista Blastomyces Quantitative Antigen

Reporting Name

MVista Blastomyces Ag

Performing Laboratory

MiraVista Diagnostics

Specimen Type


Specimen Required

Submit only one of the following:


Serum: Draw blood in a plain red-top tube(s). (Serum gel tube is acceptable.) Spin down and send 2 mL serum refrigerate in a plastic vial.


Plasma: Draw blood in EDTA, heparin or sodium citrate tube(s). Spin down and send 2 mL plasma refrigerate in a plastic vial.


Urine: Send 2 mL from a random urine collection in sterile screw cap container, shipped refrigerate.


CSF: Collect 2 mL of spinal fluid (CSF) in sterile leak proof container. Send refrigerate in a plastic vial.


Bronchoalveolar Lavage: Collect 2 mL in sterile leak proof container. Send refrigerate in a plastic vial.


Note:    1. Source is required.

            2. Separate order required for each specimen.

Specimen Minimum Volume

Blood: 1.8 mL; Serum/Plasma: 1.2 mL; CSF: 0.8 mL; Urine: 0.5 mL; BAL: 0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Varies Refrigerated (preferred) 14 days
  Ambient  14 days

Reference Values

Reference Value: None Detected

Results reported as ng/mL in 0.2 - 14.7 ng/mL range

Results above the limit of detection but below 0.2 ng/mL are reported as 'Positive, Below the Limit of Quantification'

Results above 14.7 ng/mL are reported as 'Positive, Above the Limit of Quantification'

Day(s) and Time(s) Performed

Monday through Friday

CPT Code Information


LOINC Code Information

Test ID Test Order Name Order LOINC Value
FBLAS MVista Blastomyces Ag In Process


Result ID Test Result Name Result LOINC Value
Z1033 Specimen Type In Process
Z1029 Result: In Process
Z2540 Interpretation In Process

Reject Due To










Specimen that is too viscous to pipette.

Tissue, biopsy, sputum, bronchial brush, tracheal aspirate, FNA, bone marrow aspirate, stool or samples in transport media, fixative or Isolator tubes

Test Classification

This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Method Name

Quantitative Sandwich Enzyme Immunoassay (EIA)

Secondary ID